560TiP A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations

Autor:	Harriet S. Walter, Victoria Coyle, J.S. de Bono, A. Hughes, William H. West, T. Knurowski, Nigel Brooks, Fay Ashby, Simon Pacey, Neil Anthony Pegg, Louise Carter, Simon J. Crabb, Alastair Greystoke, Ruth Plummer, Karen Clegg
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine Phase (matter) medicine In patient Hematology business
Zdroj:	Annals of Oncology. 32:S617
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.1082
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b1db034cfd21046b22dc72e01171c4a7 https://doi.org/10.1016/j.annonc.2021.08.1082 Zobrazit plný text záznamu